Bristol Myers Squibb (CELG-RI) EBITDA Margin Growth (5y) (2014 - 2026)
Bristol Myers Squibb (CELG-RI) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
| Date | Value |
|---|
| Mar 31, 2026 |
373.00 |
| Dec 31, 2025 |
12,932.00 |
| Sep 30, 2025 |
2,067.00 |
| Jun 30, 2025 |
2,021.00 |
| Mar 31, 2025 |
5,706.00 |
| Dec 31, 2024 |
3,544.00 |
| Sep 30, 2024 |
1,742.00 |
| Jun 30, 2024 |
1,643.00 |
| Mar 31, 2024 |
-10,178.00 |
| Dec 31, 2023 |
1,484.00 |
| Sep 30, 2023 |
938.00 |
| Jun 30, 2023 |
3,772.00 |
| Mar 31, 2023 |
1,543.00 |
| Dec 31, 2022 |
3,044.00 |
| Sep 30, 2022 |
2,320.00 |
| Jun 30, 2022 |
1,927.00 |
| Mar 31, 2022 |
-269.00 |
| Dec 31, 2021 |
2,720.00 |
| Sep 30, 2021 |
895.00 |
| Jun 30, 2021 |
84.00 |
